Samsara Vision, Inc. (SMSA)

Samsara Vision will go public soon. The estimated IPO date is January 28, 2022.
Stock Price: $5.00 - $7.00
Current IPO price range
Chart not available yet
Data will show when the stock starts trading on Jan 28, 2022.
Market Cap134.70M
Revenue (ttm)31,000
Net Income (ttm)-6.30M
Shares Out22.45M
EPS (ttm)-0.28
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About SMSA

Samsara Vision is a specialty medical device company dedicated to bringing vision and freedom back to patients suffering from late-stage conditions of the retina. We are engaged in the research, development, manufacturing, and marketing of proprietary ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders, particularly Age-Related Macular Degeneration (“AMD”). Our current product line consists of: our first-generation implantable miniature ...

IndustryHealth Care Equipment & Supplies
IPO DateJan 28, 2022
CEOThomas Ruggia
Employees20
Stock ExchangeNASDAQ
Ticker SymbolSMSA
Full Company Profile

Financial Performance

Financial Statements

News

Medical device maker Samsara Vision files for a $31 million IPO

Samsara Vision, which makes medical implants for retinal diseases including AMD, filed on Wednesday with the SEC to raise up to $31 million in an initial public offering.

2 months ago - Renaissance Capital

Samsara Vision IPO Registration Document (S-1)

Samsara Vision, Inc. has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC